Cargando…
The therapeutic potential of targeting the endothelial-to-mesenchymal transition
Endothelial cells (ECs) have been found to be capable of acquiring a mesenchymal phenotype through a process known as endothelial-to-mesenchymal transition (EndMT). First seen in the developing embryo, EndMT can be triggered postnatally under certain pathological conditions. During this process, ECs...
Autores principales: | Man, Shirley, Sanchez Duffhues, Gonzalo, ten Dijke, Peter, Baker, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510911/ https://www.ncbi.nlm.nih.gov/pubmed/30076548 http://dx.doi.org/10.1007/s10456-018-9639-0 |
Ejemplares similares
-
TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
por: Pardali, Evangelia, et al.
Publicado: (2017) -
TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering
por: Ma, Jin, et al.
Publicado: (2020) -
TGF-β-Induced Endothelial to Mesenchymal Transition Is Determined by a Balance Between SNAIL and ID Factors
por: Ma, Jin, et al.
Publicado: (2021) -
Inflammation induces endothelial‐to‐mesenchymal transition and promotes vascular calcification through downregulation of BMPR2
por: Sánchez‐Duffhues, Gonzalo, et al.
Publicado: (2019) -
TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
por: Hao, Yang, et al.
Publicado: (2019)